3D Bioprinted Human Tissue Market Report and Forecast 2025-2034
Description
The global 3D bioprinted human tissue market size was valued at USD 2.30 Billion in 2024, driven by growing investments in biotechnology research and development across the globe. The market is expected to grow at a CAGR of 8.40% during the forecast period of 2025-2034, with the values likely to rise from USD 2.50 Billion in 2025 to USD 5.15 Billion by 2034.
3D Bioprinted Human Tissue: Introduction
3D bioprinted human tissues are artificially manufactured functional tissues that mimic the function and architecture of native tissues. They are developed using layer-by-layer deposition of living cells, growth factors and biomaterials. 3D bioprinted human tissues are widely used in regenerative medicine providing the potential for creating organs and personalized tissues for transplantation along with drug discovery, research, and cosmetic surgeries, among others.
Global 3D Bioprinted Human Tissue Market Analysis
The 3D bioprinted human tissue market demand has grown significantly in recent years owing to its increasing application in replacing human tissues, creating biomaterial skin for wounds, skin grafting and printing living skin with blood vessels.
With rising technical advancements in biotechnology, the researchers aim at offering better techniques for quality tissue development. Digital light processing (DLP) 3D bioprinting, developed by the University of California research team is one of the latest methods used for creating a vascularized tissue that operates as a human-like living cell with biomaterial structures. There is significant development in bioinks as well, wherein HU3DINKS project has been launched by BIO INX to replace animal based bioink with human bioink is a key area of attention.
3D bioprinted human tissues showcase commercial adaptability, high experimental reproducibility, as well as industrial scalability. Consequently, it is a major area of interest amongst investors. In July 2023, 3D BioFibR, a Canadian tissue engineering company, received a USD 3.52 million funding to expand the company’s profile and develop diameter-controlled collagen fibers at a commercial scale. Such investments demonstrate that the 3D bioprinted human tissue market growth is anticipated to witness further growth in upcoming years.
Global 3D Bioprinted Human Tissue Market Segmentation
"3D Bioprinted Human Tissue Market Report and Forecast 2025-2034" offers a detailed analysis of the market based on the following segments:
Market Breakup by Tissue Type
North America, led by the United States and Canada, is anticipated to lead the 3D bioprinted human tissue market share. The market is primarily driven by rising government initiatives and investments to foster innovation in biotechnology research. In March 2023, the Government of Canada invested approximately USD 25.7 million in Aspect Biosystems, a coming-of-age biotechnology firm.
Europe is another significant player in the market with numerous academic institutions and biotechnology companies at home. The market growth can be attributed to increasing partnerships between prominent companies and institutes to develop advanced developments in the field.
Owing to the presence of economic resources and high percentage of academically talented youth, the Asia Pacific 3D bioprinted human tissue market value is projected to grow further in the forecast period. Apart from foreign investments, the government of emerging economies such as India, South Korea, and Taiwan are taking critical initiatives aimed at improving the healthcare and research infrastructure.
Global 3D Bioprinted Human Tissue Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
*Please Note:* The report will take 5 business days to complete, after order confirmation.
3D Bioprinted Human Tissue: Introduction
3D bioprinted human tissues are artificially manufactured functional tissues that mimic the function and architecture of native tissues. They are developed using layer-by-layer deposition of living cells, growth factors and biomaterials. 3D bioprinted human tissues are widely used in regenerative medicine providing the potential for creating organs and personalized tissues for transplantation along with drug discovery, research, and cosmetic surgeries, among others.
Global 3D Bioprinted Human Tissue Market Analysis
The 3D bioprinted human tissue market demand has grown significantly in recent years owing to its increasing application in replacing human tissues, creating biomaterial skin for wounds, skin grafting and printing living skin with blood vessels.
With rising technical advancements in biotechnology, the researchers aim at offering better techniques for quality tissue development. Digital light processing (DLP) 3D bioprinting, developed by the University of California research team is one of the latest methods used for creating a vascularized tissue that operates as a human-like living cell with biomaterial structures. There is significant development in bioinks as well, wherein HU3DINKS project has been launched by BIO INX to replace animal based bioink with human bioink is a key area of attention.
3D bioprinted human tissues showcase commercial adaptability, high experimental reproducibility, as well as industrial scalability. Consequently, it is a major area of interest amongst investors. In July 2023, 3D BioFibR, a Canadian tissue engineering company, received a USD 3.52 million funding to expand the company’s profile and develop diameter-controlled collagen fibers at a commercial scale. Such investments demonstrate that the 3D bioprinted human tissue market growth is anticipated to witness further growth in upcoming years.
Global 3D Bioprinted Human Tissue Market Segmentation
"3D Bioprinted Human Tissue Market Report and Forecast 2025-2034" offers a detailed analysis of the market based on the following segments:
Market Breakup by Tissue Type
- Skin
- Cartilage
- Liver
- Bone
- Heart
- Others
- Inkjet-based Bioprinting
- Extrusion-based Bioprinting
- Laser-assisted Bioprinting
- Magnetic Bioprinting
- Pharmaceutical and Biotechnology Companies
- Research Institutes and Academic Centers
- Hospitals and Clinics
- Others
- Drug Discovery
- Regenerative Medicine
- Research
- Cosmetic Surgery
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
North America, led by the United States and Canada, is anticipated to lead the 3D bioprinted human tissue market share. The market is primarily driven by rising government initiatives and investments to foster innovation in biotechnology research. In March 2023, the Government of Canada invested approximately USD 25.7 million in Aspect Biosystems, a coming-of-age biotechnology firm.
Europe is another significant player in the market with numerous academic institutions and biotechnology companies at home. The market growth can be attributed to increasing partnerships between prominent companies and institutes to develop advanced developments in the field.
Owing to the presence of economic resources and high percentage of academically talented youth, the Asia Pacific 3D bioprinted human tissue market value is projected to grow further in the forecast period. Apart from foreign investments, the government of emerging economies such as India, South Korea, and Taiwan are taking critical initiatives aimed at improving the healthcare and research infrastructure.
Global 3D Bioprinted Human Tissue Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- 3D Systems, Inc.
- Materialise NV
- Oceanz 3D printing
- Organovo
- Prellis Biologics
- SOLS Systems
- Stratasys Ltd
- The Pexion Group
- Allevi, Inc.
- Aspect Biosystems Ltd.
- Biolife 4D
- Cellbricks
- Cellink
- Microdrop
- MicroFab Technologies Inc.
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global 3D Bioprinted Human Tissue Market Overview
- 3.1 Global 3D Bioprinted Human Tissue Market Historical Value (2018-2024)
- 3.2 Global 3D Bioprinted Human Tissue Market Forecast Value (2025-2034)
- 4 Global 3D Bioprinted Human Tissue Market Landscape
- 4.1 Global 3D Bioprinted Human Tissue Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global 3D Bioprinted Human Tissue Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Technology
- 4.2.3 Analysis by Applications
- 5 Global 3D Bioprinted Human Tissue Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global 3D Bioprinted Human Tissue Market Segmentation
- 6.1 Global 3D Bioprinted Human Tissue Market by Tissue Type
- 6.1.1 Market Overview
- 6.1.2 Skin
- 6.1.3 Cartilage
- 6.1.4 Liver
- 6.1.5 Bone
- 6.1.6 Heart
- 6.1.7 Others
- 6.2 Global 3D Bioprinted Human Tissue Market by Technology
- 6.2.1 Market Overview
- 6.2.2 Inkjet-based Bioprinting
- 6.2.3 Extrusion-based Bioprinting
- 6.2.4 Laser-assisted Bioprinting
- 6.2.5 Magnetic Bioprinting
- 6.3 Global 3D Bioprinted Human Tissue Market by Applications
- 6.3.1 Market Overview
- 6.3.2 Drug Discovery
- 6.3.3 Regenerative Medicine
- 6.3.4 Research
- 6.3.5 Cosmetic Surgery
- 6.3.6 Others
- 6.4 Global 3D Bioprinted Human Tissue Market by End User
- 6.4.1 Market Overview
- 6.4.2 Pharmaceutical and Biotechnology Companies
- 6.4.3 Research Institutes and Academic Centers
- 6.4.4 Hospitals and Clinics
- 6.4.5 Others
- 6.5 Global 3D Bioprinted Human Tissue Market by Region
- 6.5.1 Market Overview
- 6.5.2 North America
- 6.5.3 Europe
- 6.5.4 Asia Pacific
- 6.5.5 Latin America
- 6.5.6 Middle East and Africa
- 7 North America 3D Bioprinted Human Tissue Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe 3D Bioprinted Human Tissue Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific 3D Bioprinted Human Tissue Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America 3D Bioprinted Human Tissue Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa 3D Bioprinted Human Tissue Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 3D Systems, Inc.
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisition
- 17.1.5 Certifications
- 17.2 Materialise NV
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisition
- 17.2.5 Certifications
- 17.3 Oceanz 3D printing
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisition
- 17.3.5 Certifications
- 17.4 Organovo
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisition
- 17.4.5 Certifications
- 17.5 Prellis Biologics
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisition
- 17.5.5 Certifications
- 17.6 SOLS Systems
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisition
- 17.6.5 Certifications
- 17.7 Stratasys Ltd
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisition
- 17.7.5 Certifications
- 17.8 The Pexion Group
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisition
- 17.8.5 Certifications
- 17.9 Allevi, Inc.
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisition
- 17.9.5 Certifications
- 17.10 Aspect Biosystems Ltd.
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisition
- 17.10.5 Certifications
- 17.11 Biolife 4D
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisition
- 17.11.5 Certifications
- 17.12 Cellbricks
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisition
- 17.12.5 Certifications
- 17.13 Cellink
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisition
- 17.13.5 Certifications
- 17.14 Microdrop
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisition
- 17.14.5 Certifications
- 17.15 MicroFab Technologies Inc.
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisition
- 17.15.5 Certifications
- 18 Global 3D Bioprinted Human Tissue Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
